Fused bicyclic carboxamide derivatives and methods of their use

Details Fused bicyclic carboxamide derivatives and methods of their use Fused bicyclic carboxamide derivatives and methods of their use

2006-04-25

2006-04-25

Lambkin, Deborah C. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S525000

Reexamination Certificate

active

07034051

ABSTRACT:
Fused bicyclic carboxamide derivatives are disclosed. Pharmaceutical compositions containing the compounds and methods for their use are also disclosed.

REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5109135 (1992-04-01), D'Ambra et al.
patent: 5242944 (1993-09-01), Park et al.
patent: 5345943 (1994-09-01), Hargreaves et al.
patent: 5369131 (1994-11-01), Poli et al.
patent: 5434292 (1995-07-01), Saita et al.
patent: 5532266 (1996-07-01), Gottschlich et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5804595 (1998-09-01), Portoghese et al.
patent: 6057357 (2000-05-01), Horwell et al.
patent: 6177438 (2001-01-01), Nagase et al.
patent: 6713502 (2004-03-01), Dhanak et al.
patent: 6747054 (2004-06-01), Cameron et al.
patent: 6784167 (2004-08-01), Wood et al.
patent: 6784197 (2004-08-01), Differding et al.
patent: 0 254 545 (1988-01-01), None
patent: 0 261 842 (1988-03-01), None
patent: WO 91/08206 (1991-06-01), None
patent: WO 98/49141 (1998-11-01), None
patent: WO 99/32475 (1999-07-01), None
Jain, K.K., “A guide to drug evaluation for chronic pain,”Emerging Drugs, 2000, 5(2), 241-257.
Andreev, N., et al., “Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation,”Neurosci., 1994, 58(4), 793-798.
Antonijevic, I., et al., “Perineurial defect and peripheral opioid analgesia in inflammation,”J. Neurosci., Jan. 1995, 15(1), 165-172.
Barber, A., et al., “Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation,”Med. Res. Rev., 1992, 12(5), 525-562.
Buschmann, H., et al., (Eds.),Analgesics, Wiley-VCH, Verlag GMbH & Co. KgaA, Weinheim, 2002.
Flynn, G., “Mechanism of percutaneous absorption from physicochemical evidence,”Percutaneous Absorption, Bronaugh, R.L., et al. (Eds.), Marcel Dekker, Inc., 1985, Chapter 2, 17-42.
Greene, T.W., et al.,Protective Groups in Organic Synthesis, 2ndEd., Wiley & Sons, 1991.
Handwerker, H.O., et al., “Pain and Inflammation,”Proceedings of the VIthWorld Congress on Pain, Bond, et al. (Eds.),Elsevier Science Publishers BV, 1991, Chapter 7, 59-70.
Hargreaves, K.M., et al., “The peripheral analgesic effects of opioids,”APS Journal, 1993, 2(1), 51-59.
Hassan, A.H., et al., “Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increase their density in the inflamed tissue,”Neuroscience, 1993, 55(1), 185-195.
Iyengar, S., et al., “Kappaopiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat,”J. Pharmacol. Exp. Ther., 1986, 238(2), 429-436.
Leander, J.D., et al., “Diuresis and suppression of vasopressin byKappaopioids: comparison withMuandDeltaopioids and clonidine,”J. Pharmacol. Exp. Ther., 1985, 234(2), 463-469.
Lutz, R.A., et al., “Opioid receptors and their pharmacological profiles,”J. Recept. Res., 1992, 12(3), 267-286.
Mansour, A., et al., “Anatomical distribution of opioid receptors in mammalians: an overview,”Opioids I, A. Herz (Ed.), Springer-Verlag, 1993, 79-105.
Manzanares, J., et al., “Kappa-opioid-receptor-mediated regulation to α-melanocyte-stimulating hormone secretion and tuberohypophysical dopaminergic neuronal activity,”Neuroendrocrinology, 1990, 52, 200-205.
Millan, M.J., “κ-opioid receptors and analgesia,”Trends in Pharmacol. Sci., Feb. 1990, 11, 70-76.
Morley, J.E., et al., “Involvement of dynorphin and the kappa opioid receptor in feeding,”Peptides, 1983, 4, 797-800.
Neugebauer, V., et al., “N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint,”J. Neurophysiology, Oct. 1993, 70(4), 1365-1377.
Pershing, L.K., et al., “In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum,”Antimicrob. Agents Chemother., Jan. 1994, 38(1), 90-95.
Przewlocki, R., et al., “Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception,”Neuroscience, 1992, 48(2), 491-500.
Ramabadran, K., et al., “A critical analysis of the experimental evaluation of nonciceptive reactions in animals,”Pharm. Res., 1986, 3(5), 263-270.
Randall, L.O., et al., “A method for measurement of analgesic activity on inflamed tissue,”Arch. Int. Pharmacodyn., 1957,CXI(4), 409-419.
Remington's Pharmaceutical Sciences,Mack Publishing Co., Easton, PA, 1980.
Roy, S.D., et al., “Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil,”Pharm. Res., 1990, 7(8), 842-847.
Sato, A., et al., “Changes in blood pressure and heart rate induced by movements of normal and inflamed knee joints,”Neurosci. Lett., 1984, 52, 55-60.
Schaible, H.-G., et al, “Effects of an experimental arthritis on the sensory properties of fine articular afferent units,”J. Neurophysiol., Nov. 1985, 54(5), 1109-1122.
Schaible, H.-G., et al., “Afferent and spinal mechanisms of joint pain,”Pain, 1993, 55, 5-54.
Simon, E.J., “Opioid receptors and endogenous opioid peptides,”Med. Res. Rev., 1991, 11(4), 357-374.
Stein, C., et al., “Peripheral opioid receptors mediating antinociception in inflammation. Evidence of involvement ofMu, DeltaandKappareceptors,”J. Pharmacol. and Exp. Ther., 1989, 248(3), 1269-1275.
Stein, C., et al., “Peripheral effect of fentanyl upon nociception in inflamed tissue of the rate,”Neurosci. Lett., 1988, 84, 225-228.
Taber, R.I., et al., “Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice,”J. Pharmacol. Exp. Ther., 1969, 169(1), 29-38.
Tjølsen, A., et al., “The formalin test: an evaluation of the method,”Pain, 1992, 51, 5-17.
Wheeler-Aceto, H., et al., “Standardization of the rat paw formalin test for the evaluation of analgesics,”Psychopharmacology, 1991, 104, Springer-Verlag, 35-44.
Williamson, J.W., et al., “Reflex increase in blood pressure induced by leg compression in man,”J. Physiol., 1994, 475.2, 351-357.
Wood, P.L., “Multiple opiate receptors: support for unique mu, delta and kappa sites,”Neuropharmacology, 1982, 21, 487-497.

Affiliated with

Also associated with

Rating

Fused bicyclic carboxamide derivatives and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused bicyclic carboxamide derivatives and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic carboxamide derivatives and methods of their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3574972